Nathalie Riebel of Oncospire Consultants helping biotech leadership team review trial strategy

Get back in the driver’s seat of your own trial.

I build the oversight systems that provide visibility into your CRO and keep your trial on track.

Many small biotech clinical leaders lack
visibility into their own CRO relationship

Stressed biotech clinical leader reviewing trial updates and CRO performance at desk

Does any of this sound familiar?

  • Wasting time chasing updates from a vendor that should already be reporting to you.

  • Paying invoices you cannot connect to a clinical outcome or milestone.

  • Finding out your timeline slipped after it was already too late to fix.

  • Walking into board meetings without clear answers about trial progress.

  • A 2-person team responsible for overseeing a 30-person CRO organization.

You deserve a simple oversight method
that puts you in control of your trial.

Stop paying for activities that don't move your trial forward.

Trust Your CRO Partner

Trust Your CRO Partner

Build a relationship with a CRO that shares your priorities, your culture, and your urgency.

Reclaim Your Time

Reclaim Your Time 

Stop micromanaging your CRO and get back to the work that actually grows your company and your career.

Lead with Confidence 

Walk into every board and CEO meeting with the data you need to make decisions and defend your budget.


90% of trials fall behind. 

Here is how to be in the 10% that stay on track.

I get it. Being accountable for a trial you cannot fully see is frustrating.

Clinical trial consultant Nathalie Riebel of Oncospire presenting CRO oversight strategy to biotech leadership team

You want to be a recognized leader. The kind who walks into a board meeting prepared and runs a trial that actually delivers results. In order to do that you need full visibility into what your CRO and other vendors are doing and why.

The problem is most small biotech clinical teams are operating without a real oversight method. They are managing a 30-person CRO with a lean internal team and no system built for that reality. This can leave you feeling frustrated and powerless.

Clinical operations leaders deserve a clear oversight method that puts them back in control of their trial. I know how high the stakes are because I have spent 36 years inside pharmaceutical companies, CROs, and small biotech organizations. I have seen how easily misalignment with a CRO can stall a trial, waste precious budget, and delay treatments patients are waiting for. That experience now guides the work I do with clinical leaders who want full visibility, alignment, and momentum.

Here’s what makes my approach unique:

  • I have worked inside large pharma, mid-size pharma, CROs, and small biotech. I know where the gaps live.

  • I help you select the right CRO before the relationship starts, matched to your science and culture.

  • I build clinical momentum with an oversight method for your team and train them to use them, so the change sticks.

You have the expertise to lead this trial. Let me give you the system to do it with clarity.

Nathalie Riebel signature

Nathalie Riebel, BSc. MBA
Founder, Oncospire | Clinical Momentum Method

Clinical trial consultant Nathalie Riebel of Oncospire Consultants specializing in CRO selection and oversight systems

36

Years inside pharma, CRO, and small biotech

5

Years, Eli Lilly Inspection Readiness Leader, 27+ Global agency inspections

33

Years in Oncology Clinical Ops, Development and PM

Here’s how it works

Step 1

Book Your Clinical Momentum Call

We identify exactly where your CRO relationship or oversight method is breaking down and map the fastest path to getting you back in control.

Step 2

Build Your Oversight System 

We diagnose the root cause, align your CRO or vendor to your priorities, and put the right oversight methods and tools in place for your team and your trial.

Step 3

Lead Your Trial with Confidence

Walk into every board meeting with real data. See risks before they become misses. Trust your CRO as a genuine partner. And get back to the work that actually grows your company and your career.

The Clinical Momentum Method

Diagram showing the three components of the Clinical Momentum Method: Visibility, Alignment, and Control, working together to improve CRO oversight and trial management

Don't let a misaligned CRO put your trial,
your funding, and your patients at risk.

Together we will build the oversight method your trial needs so you can lead with confidence, protect your timeline, and never walk into a board meeting unprepared again.

Where Would You Like to Start?

Handshake icon representing CRO vendor selection and partnership alignment

Vendor Selection Package

Choose the right CRO from the start, matched to your science, your culture, and your operational needs.  |  6 week engagement.

Magnifying glass icon representing clinical trial visibility and critical path assessment

Critical Path Visibility Assessment

Identify where your CRO relationship is breaking down and map the fastest path to getting back on track.  |  10 day engagement

Rocket icon representing accelerated clinical trial momentum and faster execution

Clinical Momentum Sprint

Build your oversight tools, align your CRO to your priorities, and train your team to sustain the process.  |  6 week engagement.

Shield and compass icon representing strategic clinical trial oversight and guidance

Clinical Momentum Method Advisory

Maintain full visibility, alignment, and momentum across your trial at every stage of development.  |  6 month engagement.

FREE GUIDE / VIDEO 

The CRO Oversight Gaps Most Leaders Miss

Find out where your CRO oversight is breaking down before it costs you a milestone.

Clinical trial consultant Nathalie Riebel of Oncospire Consultants presenting CRO oversight phases for biotech leadership team
  • Discover the five most common oversight gaps

  • See where clinical leaders lose visibility and control

  • Know the first place to focus to protect your trial